Keros Therapeutics
KROS
KROS
98 hedge funds and large institutions have $944M invested in Keros Therapeutics in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more funds holding
Funds holding: 88 → 98 (+10)
9.93% more ownership
Funds ownership: 59.12% → 69.05% (+9.9%)
Holders
98
Holding in Top 10
5
Calls
$6.57M
Puts
$5K
Top Buyers
| 1 | +$22.2M | |
| 2 | +$19.9M | |
| 3 | +$13.2M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.78M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$8.4M |
Top Sellers
| 1 | -$7.56M | |
| 2 | -$6.53M | |
| 3 | -$5.74M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.08M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.01M |